-
-
-
-
-
-
-
Lantheus completes Life Molecular Imaging acquisition, names new R&D head
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Completes Acquisition of Evergreen Theragnostics
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) o Acquire Life Molecular Imaging for an Upfront Payment of $350 Million
-
-
-
-
-
-
-
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Announces CEO Succession, Updates Guidance
-
-
-
-
-
-
-
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
-
-
-
-
-
-
-
Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

